UNICYCIVE THERAPEUTICS, INC. Increase (Decrease) in Other Current Assets
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Increase (Decrease) in Other Current Assets of $771.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2023-08-14
- UNICYCIVE THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2023-06-30 was $1.11M.
- UNICYCIVE THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2023-03-31 was -$338.00K.
- UNICYCIVE THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2022-12-31 was $335.00K.
- UNICYCIVE THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2022-09-30 was $228.00K.
- UNICYCIVE THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2022 was -$62.00K, a 104.68% decline from fiscal 2021.
- UNICYCIVE THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2021 was $1.32M.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $771.00K 10-Q · filed 2023-08-14 | $1.11M derived: sum of 3 quarters · filed 2023-08-14 | $1.33M derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | -$338.00K 10-Q · filed 2023-05-16 | -$3.00K derived: sum of 2 quarters · filed 2023-05-16 | $225.00K derived: sum of 3 quarters · filed 2023-05-16 | -$137.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $563.00K derived: sum of 2 quarters · filed 2023-03-31 | $201.00K derived: sum of 3 quarters · filed 2023-08-14 | -$62.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $228.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$134.00K derived: sum of 2 quarters · filed 2023-08-14 | -$397.00K 10-Q · filed 2022-11-14 | -$781.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | -$362.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$625.00K 10-Q · filed 2023-08-14 | -$1.01M derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$263.00K 10-Q · filed 2023-05-16 | -$647.00K derived: sum of 2 quarters · filed 2023-05-16 | ||
| 2021-12-31 | -$384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.32M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $1.71M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |